Certification Rate
94.4%
Moderate DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Mahwah, NJ NAICS: 424210
U.S. Department of Labor's OFLC discloses 18 Labor Condition Application filings naming Glenmark Pharmaceuticals, Inc. USA from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 28 H-1B petitions naming Glenmark Pharmaceuticals, Inc. USA through FY2024, and approved the large majority of them: 96.4% approved (27 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Glenmark Pharmaceuticals, Inc. USA is listed in 18 DOL LCA filings, more filings than 90% of employer filers in this extract. DOL certified 94.4% of those LCAs; the median listed offered wage is $160,695. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Mahwah, NJ.
Glenmark Pharmaceuticals, Inc. USA LCA outcome mix
18DOL LCA filings on record
Glenmark Pharmaceuticals, Inc. USA vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
18 12320th of 122824 higher than 110,504 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $105,000–$315,000 .
DOL LCA release change
On 18 LCAs with comparable offered vs prevailing wages, Glenmark Pharmaceuticals, Inc. USA averages about 30.2% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Experienced (Level III) (66.7% of LCA filings).
Certification Rate
94.4%
Moderate DOL cert
Avg. Salary
$160,695
Well above portal avg
Total Workers
18
Small worker count
Compensation range for H-1B positions at Glenmark Pharmaceuticals, Inc. USA
Wage vs. DOL Minimum
+30.2%
High vs DOL floor
national avg +17.8%
Typical DOL Wage Level
Experienced (Level III)
66.7% of LCA filings
Full-Time Positions
100%
Primary Worksite County
UNION, NC
61.1% of LCA filings
Most frequently listed job titles at Glenmark Pharmaceuticals, Inc. USA
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Validation Specialist | 4 | $108,105 |
| Manufacturing, Science & Technology (MSAT) Manager | 3 | $137,726 |
| Site Quality Head | 2 | $315,000 |
| Senior Director “ Quality, North America | 2 | $210,000 |
| Sterile Injectable Supervisor | 1 | $105,000 |
| Senior Validation Specialist | 1 | $123,058 |
| Senior Research Scientist | 1 | $125,000 |
| Senior Manager- QC Stability | 1 | $139,616 |
| Senior MSAT Specialist | 1 | $111,662 |
| Director of Quality Assurance | 1 | $192,571 |
| DIRECTOR ENGINEERING & PROJECTS | 1 | $200,000 |
Cross-state DOL neighbors for Glenmark Pharmaceuticals, Inc. USA - LCA filing-count and offered-wage axes, outside NJ.
Nearest cross-state employer filers by LCA filing count (18 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($160,695 here).
Glenmark Pharmaceuticals, Inc. USA is listed in 18 DOL Labor Condition Application filings covering 18 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Glenmark Pharmaceuticals, Inc. USA ranks #11818 by total LCA filing count (18 filings). 110,504 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Glenmark Pharmaceuticals, Inc. USA has a 94.4% DOL certification rate, with 17 out of 18 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Glenmark Pharmaceuticals, Inc. USA's LCAs is $160,695. Listed wages range from $105,000 to $315,000 and are not verified actual compensation.
The top job titles in Glenmark Pharmaceuticals, Inc. USA's LCA filing records include Validation Specialist, Manufacturing, Science & Technology (MSAT) Manager, Site Quality Head. The most common listed title is Validation Specialist with 4 LCA filings at an average listed offered wage of $108,105. This does not establish actual job openings, hiring, or approved petitions.
Glenmark Pharmaceuticals, Inc. USA is headquartered in Mahwah, NJ. Their H-1B workers are distributed across 2 states, with the most positions in NC, NJ.
No, Glenmark Pharmaceuticals, Inc. USA is not classified as H-1B dependent.
Glenmark Pharmaceuticals, Inc. USA is listed in 2 LCA filings in FY2023 and 2 in FY2026. The average listed offered wage increased from $107,000 to $141,589. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Glenmark Pharmaceuticals, Inc. USA); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Glenmark Pharmaceuticals, Inc. USA); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Glenmark Pharmaceuticals, Inc. USA); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Glenmark Pharmaceuticals, Inc. USA); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
NJ pole at 39,678 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Glenmark Pharmaceuticals, Inc. USA's MICRO-BOOK.
Open the NJ state board after the ABS peers. Glenmark Pharmaceuticals, Inc. USA stamps MICRO-BOOK · CERT-SOLID inside that worksite mix.
Glenmark Pharmaceuticals, Inc. USA's CERT-SOLID stamp sits below CERT-CLEAN. Start with how LCA certification works.
What to do with this profile
Use the DOL LCA record for Glenmark Pharmaceuticals, Inc. USA to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.